Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center
| Image |  |
|---|---|
| Description | scientific article published on 12 October 2012 |
| Author/s |
author: Tim M. Illidge John Radford Kim Linton |
| Publication date | October 12, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |